Professionalism

Centering Equity in Digital Health Solution Evaluation

Digital tools can improve health and health care. However, if such technology is not designed, implemented, and evaluated with a focus on equity, it can worsen inequities. Historical and current injustices in the way that health interventions, including digital health…

Maternal Sepsis, Part 6: Risk Mitigation

Sepsis is the third leading cause of pregnancy-related death accounting for 23% of maternal deaths in the United States. To promote early recognition and rapid treatment, multiple professional organizations have provided screening and diagnostic criteria, and treatment recommendations. This series…

Maternal Sepsis, Part 5: Treating

Sepsis is the third leading cause of pregnancy-related death accounting for 23% of maternal deaths in the United States. To promote early recognition and rapid treatment, multiple professional organizations have provided screening and diagnostic criteria, and treatment recommendations. This series…

Labor Induction-Module 7: Oxytocin Safe Administration

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 6: Oxytocin Pharmacodynamics

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 5: Misoprostol

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 4: Mechanical Methods

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 3: Cervical Ripening

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 1: Verdicts, Settlements, and a Case Study

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…